Update on fibromyalgia therapy

Area of Science:

• Rheumatology
• Pain Medicine
• Clinical Pharmacology

Background:

• Fibromyalgia is a chronic pain syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and psychological distress.
• Its exact cause remains unclear, but central pain processing dysfunction is implicated in its pathogenesis.
• Current pharmacological treatments for fibromyalgia have shown limited efficacy, with only one FDA-approved drug available.

Purpose of the Study:

• To systematically review and critically evaluate clinical investigations of both medicinal and nonmedicinal treatments for fibromyalgia.
• To assess the effectiveness of various therapeutic interventions for fibromyalgia syndrome.

Main Methods:

• Systematic literature review of clinical investigations.
• Evaluation of studies on fibromyalgia treatments published between 1970 and 2007.
• Analysis of both pharmacological and non-pharmacological interventions.

Main Results:

• No single drug or drug class has demonstrated consistent, widespread efficacy for fibromyalgia patients.
• Limited evidence supports the effectiveness of many studied treatments.
• The review covers a broad range of interventions evaluated over several decades.

Conclusions:

• Despite extensive research, effective treatments for fibromyalgia remain limited.
• Further research is needed to identify and validate successful therapeutic strategies for fibromyalgia.
• The review highlights the ongoing challenges in managing this complex chronic pain condition.